Ignite Creation Date:
2024-06-16 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06421298
Status:
RECRUITING
Last Update Posted:
2024-05-20
First Post:
2024-05-10
Brief Title:
A Prospective Single-arm Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy
Sponsor:
Organization:
Beijing Chest Hospital Capital Medical University